Figure Gallery

Expression Pattern Search Results for fabp10a

(116 figures with expression from 79 publications)

[ Show only figures with images ]
Publication	Data	Fish	Condition	Stage Range	Anatomy
Nissim et al., 2016	Fig. 2	WT nr5a2^oz3/oz3 nr5a2^oz3/+	standard conditions	Protruding-mouth to Day 4	hepatocyte liver
	Fig. 7	WT	control chemical treatment: 1-(3'-{1-[2-(morpholin-4-yl)ethyl]pyrazol-3-yl}[1,1'-biphenyl]-3-yl)ethan-1-one	Protruding-mouth	liver
Reuter et al., 2016	Fig. 1	AB	chemical treatment by environment: paracetamol	Protruding-mouth	liver
San et al., 2016	Fig. 6	ezh2^hu5670/+	standard conditions	Long-pec	liver
Shan et al., 2016	Fig. 2	AB	bacterial treatment by exposure to environment: Listeria monocytogenes EGD-e, germ free	Day 5	whole organism
Gao et al., 2015	Fig. 3	AB/TU AB/TU + MO1-fgl1b	standard conditions control	Long-pec to Day 4	liver
Khaliq et al., 2015	Fig. 3	WT WT + MO1-id2a	standard conditions control	Long-pec to Protruding-mouth	hepatocyte
Liu et al., 2015	Fig. S7	TU dnmt1^rj794/rj794 (TU)	control	Day 4	hepatocyte
Yang et al., 2015	Fig. 4	AB AB + MO2-nup62l	control	Protruding-mouth	liver
Chen et al., 2014	Fig. 4	WT	control chemical treatment: tunicamycin	Day 5	liver
Cox et al., 2014	Fig. 3	WT npas4l^{unspecified/unspecified} WT + MO1-adh5	control standard conditions chemical treatment: pharmaceutical chemical treatment: pharmaceutical chemical treatment: pharmaceutical chemical treatment: pharmaceutical chemical treatment: pharmaceutical	Protruding-mouth	liver
	Fig. 2	WT WT + MO1-nos1 WT + MO1-nos2a	standard conditions standard conditions control	Protruding-mouth	liver
	Fig. 1	WT	control chemical treatment: pharmaceutical chemical treatment: pharmaceutical	Protruding-mouth	liver
Niu et al., 2014	Fig. 4	WT WT + MO1-sec31b WT + MO1-sec31a + MO1-sec31b	standard conditions standard conditions control	Protruding-mouth	liver
	Fig. 5	WT	control chemical treatment: pharmaceutical	Protruding-mouth	liver
Liu et al., 2013	Fig. 3	WT WT + MO1-cpn1 WT + MO1-fads2 WT + MO1-mapk10 WT + MO1-pklr WT + MO1-pnpla3 WT + MO1-samm50 WT + MO1-slc2a2 WT + MO1-trib1	standard conditions standard conditions standard conditions standard conditions standard conditions standard conditions standard conditions standard conditions control	Protruding-mouth	liver
	Fig. 4	WT	standard conditions chemical treatment: drug	Day 4	liver
Liu et al., 2013	Fig. 2	WT WT + MO3-zfyve9a WT + MO4-zfyve9a	standard conditions standard conditions control	Protruding-mouth to Day 4	hepatocyte
Parmar et al., 2013	Fig. 6	WT	standard conditions	Adult	brain eye gill heart intestine kidney liver ovary swim bladder testis
Stuckenholz et al., 2013	Fig. 7	WT WT + MO1-sfrp5	standard conditions control	Protruding-mouth	liver
Garnaas et al., 2012	Fig. 3	WT WT + MO1-raraa WT + MO1-rarab WT + MO1-rarga WT + MO1-rargb	standard conditions standard conditions standard conditions standard conditions control	Protruding-mouth	liver
	Fig. 2	WT WT + MO2-aldh8a1 WT + MO3-aldh1a2	standard conditions standard conditions control	Protruding-mouth	liver
	Fig. 1	WT	control chemical treatment: all-trans-retinoic acid chemical treatment: 4-(diethylamino)benzaldehyde	Protruding-mouth	liver
Hozumi et al., 2012	Fig. S6	WT ddx46^ha4/ha4 (AB)	standard conditions	Protruding-mouth	liver
	Fig. S7	WT ddx46^ha4/+; ddx46^hi2137Tg/+	standard conditions	Protruding-mouth	liver